Assisted reproductive technologies: Medical safety issues in the older woman

Journal of Women's Health

Volumn 20, Issue 6, 2011, Pages 853-861

  Segev, Yakir ^a   Riskin Mashiah, Shlomit ^a   Lavie, Ofer ^a   Auslender, Ron ^a  

^a CARMEL MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RISK; CARDIOVASCULAR DISEASE; CLINICAL PROTOCOL; COUNSELING; DIABETES MELLITUS; FEMALE; HUMAN; HYPERTENSION; INFERTILITY THERAPY; MATERNAL AGE; MEDICAL EXAMINATION; METABOLIC SYNDROME X; NEOPLASM; OBESITY; PATIENT ASSESSMENT; PATIENT SAFETY; PRIORITY JOURNAL; QUESTIONNAIRE; REVIEW; RISK ASSESSMENT; RISK FACTOR; WOMEN'S HEALTH;

ADULT; AGE FACTORS; CHRONIC DISEASE; FEMALE; HUMANS; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PRENATAL CARE; REPRODUCTIVE TECHNIQUES, ASSISTED; RISK FACTORS;

EID: 79959322772     PISSN: 15409996     EISSN: 1931843X     Source Type: Journal    
DOI: 10.1089/jwh.2010.2603     Document Type: Review

References (110)

1. Tarlatzis BC, Zepiridis L. Perimenopausal conception. Ann NY Acad Sci 2003;997:93-104. (Pubitemid 38491063)
2. Chambers GM, Sullivan EA, Ishihara O, Chapman MG, Adamson GD. The economic impact of assisted reproductive technology: A review of selected developed countries. Fertil Steril 2009;91:2281-2294.
3. Kuklina E, Callaghan W. Chronic heart disease and severe obstetric morbidity among hospitalisations for pregnancy in the USA: 1995-2006. Br J Obstet Gynaecol 2011;118:345-352.
4. Kuklina EV, Ayala C, Callaghan WM. Hypertensive disorders and severe obstetric morbidity in the United States. Obstet Gynecol 2009;113:1299-1306.
5. Clutton-Brock TH, Lewis G. Saving mothers' lives reviewing maternal deaths to make motherhood safer - 2003-2005: The seventh Report on the Confidential Enquiries into Maternal Deaths in the United Kingdom. London: Confidential Enquiry into Maternal and Child Health (CEMACH), 2007.
6. Montan S. Increased risk in the elderly parturient. Curr Opin Obstet Gynecol 2007;19:110-112. (Pubitemid 46412098)
7. Berg CJ, Harper MA, Atkinson SM, et al. Preventability of pregnancy-related deaths: Results of a state-wide review. Obstet Gynecol 2005;106:1228-1234.
8. Devroey P, Fauser BC, Diedrich K. Approaches to improve the diagnosis and management of infertility. Hum Reprod Update 2009;15:391-408.
9. Paulson RJ, Boostanfar R, Saadat P, et al. Pregnancy in the sixth decade of life: Obstetric outcomes in women of advanced reproductive age. JAMA 2002;288:2320-2323. (Pubitemid 35291763)
10. Grainger DA, Frazier LM, Rowland CA. Preconception care and treatment with assisted reproductive technologies. Matern Child Health J 2006;10:S161-S164.
11. Healthier mothers and babies. MMWR 1999;48:849-858.
12. Say L. UNICEF, United Nations Population Fund, World Health Organization, Reproductive Health and Research, World Bank. Maternal mortality in 2005 estimates developed by WHO, UNICEF, UNFPA and the World Bank. Geneva: World Health Organization, 2007.
13. Bianco A, Stone J, Lynch L, Lapinski R, Berkowitz G, Berkowitz RL. Pregnancy outcome at age 40 and older. Obstet Gynecol 1996;87:917-922. (Pubitemid 26159383)
14. Callaghan WM, Berg CJ. Pregnancy-related mortality among women aged 35 years and older, United States, 1991-1997. Obstet Gynecol 2003;102:1015-1021.
15. Delpisheh A, Brabin L, Attia E, Brabin BJ. Pregnancy late in life: a hospital-based study of birth outcomes. J Womens Health 2008;17:965-970.
16. Gilbert WM, Nesbitt TS, Danielsen B. Childbearing beyond age 40: Pregnancy outcome in 24,032 cases. Obstet Gynecol 1999;93:9-14.
17. Jacobsson B, Ladfors L, Milsom I. Advanced maternal age and adverse perinatal outcome. Obstet Gynecol. 2004;104:727-733. (Pubitemid 40458800)
18. Jolly M, Sebire N, Harris J, Robinson S, Regan L. The risks associated with pregnancy in women aged 35 years or older. Hum Reprod 2000;15:2433-2437.
19. Salihu HM, Shumpert MN, Slay M, Kirby RS, Alexander GR. Childbearing beyond maternal age 50 and fetal outcomes in the United States. Obstet Gynecol 2003;102:1006-1014. (Pubitemid 37412292)
20. Vercellini P, Zuliani G, Rognoni MT, Trespidi L, Oldani S, Cardinale A. Pregnancy at forty and over: A case-control study. Eur J Obstet Gynecol Reprod Biol 1993;48:191-195. (Pubitemid 23141991)
21. Weerasekera DS, Udugama SG. Pregnancy at 40 and over: A case-control study in a developing country. J Obstet Gynaecol 2003;23:625-627. (Pubitemid 37475899)
22. Ziadeh S, Yahaya A. Pregnancy outcome at age 40 and older. Arch Gynecol Obstet 2001;265:30-33. (Pubitemid 32231622)
23. Naser KA, Gruber A, Thomson GA. The emerging pandemic of obesity and diabetes: Are we doing enough to prevent a disaster? Int J Clin Pract 2006;60:1093-1097.
24. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006;295:1549-1555.
25. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010;303:235-241.
26. Loret DM Jr. Obesity and its relationship to infertility in men and women. Obstet Gynecol Clin North Am 2009;36:333-346.
27. Yogev Y, Catalano PM. Pregnancy and obesity. Obstet Gynecol Clin North Am 2009;36:285-300.
28. Robinson HE, O'Connell CM, Joseph KS, McLeod NL. Maternal outcomes in pregnancies complicated by obesity. Obstet Gynecol 2005;106:1357-1364. (Pubitemid 41668957)
29. Conde-Agudelo A, Belizan JM. Risk factors for preeclampsia in a large cohort of Latin American and Caribbean women. Br J Obstet Gynaecol 2000;107:75-83. (Pubitemid 30042729)
30. Cedergren MI. Maternal morbid obesity and the risk of adverse pregnancy outcome. Obstet Gynecol 2004;103:219-224.
31. Veleva Z, Tiitinen A, Vilska S, et al. High and low BMI increase the risk of miscarriage after IVF/ICSI and FET. Hum Reprod 2008;23:878-884.
32. Rasmussen SA, Chu SY, Kim SY, Schmid CH, Lau J. Maternal obesity and risk of neural tube defects: A metaanalysis. Am J Obstet Gynecol 2008;198:611-619. (Pubitemid 351758926)
33. Shaw GM, Todoroff K, Schaffer DM, Selvin S. Maternal height and prepregnancy body mass index as risk factors for selected congenital anomalies. Paediatr Perinat Epidemiol 2000;14:234-239. (Pubitemid 30599071)
34. Watkins ML, Rasmussen SA, Honein MA, Botto LD, Moore CA. Maternal obesity and risk for birth defects. Pediatrics 2003;111:1152-1158. (Pubitemid 36539220)
35. Roglic G, Unwin N, Bennett PH, et al. The burden of mortality attributable to diabetes: Realistic estimates for the year 2000. Diabetes Care 2005;28:2130-2135.
36. Cowie CC, Rust KF, Byrd-Holt DD, et al. Prevalence of diabetes and impaired fasting glucose in adults in the U.S. population: National Health and Nutrition Examination Survey 1999-2002. Diabetes Care 2006;29:1263-1268.
37. Feig DS, Palda VA. Type 2 diabetes in pregnancy: A growing concern. Lancet 2002;359:1690-1692. (Pubitemid 34518536)
38. Martin JA, Hamilton BE, Sutton PD, et al. Births: Final data for 2005. Natl Vital Stat Rep 2007;56:1-103.
39. Macintosh MC, Fleming KM, Bailey JA, et al. Perinatal mortality and congenital anomalies in babies of women with type 1 or type 2 diabetes in England, Wales, and Northern Ireland: Population based study. BMJ 2006;333:177.
40. Ray JG, O'Brien TE, Chan WS. Preconception care and the risk of congenital anomalies in the offspring of women with diabetes mellitus: A meta-analysis. Q J Med 2001;94:435-444. (Pubitemid 32776286)
41. Melamed N, Hod M. Perinatal mortality in pregestational diabetes. Int J Gynaecol Obstet 2009;104 (Suppl 1):S20-S24.
42. Kitzmiller JL, Buchanan TA, Kjos S, Combs CA, Ratner RE. Pre-conception care of diabetes, congenital malformations, and spontaneous abortions. Diabetes Care 1996;19:514-541. (Pubitemid 26143759)
43. Langer O, Conway DL. Level of glycemia and perinatal outcome in pregestational diabetes. J Matern Fetal Med 2000;9:35-41. (Pubitemid 30176210)
44. Galindo A, Burguillo AG, Azriel S, Fuente PL. Outcome of fetuses in women with pregestational diabetes mellitus. J Perinat Med 2006;34:323-331. (Pubitemid 44114572)
45. Preconception care of women with diabetes. Diabetes Care 2004;27 (Suppl 1):S76-S78.
46. Cunningham FG, Williams JW. In: Cunningham FG, Hauth JC, Wenstrom KD, Leveno KJ, Gilstrip L III, Bloom SL, eds. Williams obstetrics, 22nd ed. New York: McGraw-Hill, 2005.
47. Evers IM, de Valk HW, Visser GH. Risk of complications of pregnancy in women with type 1 diabetes: Nationwide prospective study in the Netherlands. BMJ 2004;328:915.
48. Chan BC, Lao TT. Gestational diabetes mellitus in women in the fourth decade - Is treatment worthwhile? Gynecol Obstet Invest 2005;60:112-116.
49. Kuklina EV, Yoon PW, Keenan NL. Prevalence of coronary heart disease risk factors and screening for high cholesterol levels among young adults, United States, 1999-2006. Ann Fam Med 2010;8:327-333.
50. Ray JG, Burrows RF, Burrows EA, Vermeulen MJ. MOS HIP: McMaster outcome study of hypertension in pregnancy. Early Hum Dev 2001;64:129-143. (Pubitemid 32618662)
51. McCowan LM, Buist RG, North RA, Gamble G. Perinatal morbidity in chronic hypertension. Br J Obstet Gynaecol 1996;103:123-129. (Pubitemid 26054525)
52. American College of Obstetricians and Gynecologists. Practice bulletin. Chronic hypertension in pregnancy. ACOG Committee on Practice Bulletins. Obstet Gynecol 2001;98(Suppl):85.
53. Sibai BM, Lindheimer M, Hauth J, et al. Risk factors for preeclampsia, abruptio placentae, and adverse neonatal outcomes among women with chronic hypertension. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 1998;339:667-671.
54. Mackay AP, Berg CJ, Atrash HK. Pregnancy-related mortality from preeclampsia and eclampsia. Obstet Gynecol 2001;97:533-538.
55. Lanska DJ, Kryscio RJ. Risk factors for peripartum and postpartum stroke and intracranial venous thrombosis. Stroke 2000;31:1274-1282. (Pubitemid 30351245)
56. Miller JH, Weinberg RK, Canino NL, Klein NA, Soules MR. The pattern of infertility diagnoses in women of advanced reproductive age. Am J Obstet Gynecol 1999;181:952-957. (Pubitemid 29503622)
57. Essah PA, Nestler JE. The metabolic syndrome in polycystic ovary syndrome. J Endocrinol Invest 2006;29:270-280.
58. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: Findings from the third National Health and Nutrition Examination Survey. JAMA 2002;287:356-359. (Pubitemid 34251969)
59. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome: Prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2003;163:427-436.
60. Alexander CJ, Tangchitnob EP, Lepor NE. Polycystic ovary syndrome: A major unrecognized cardiovascular risk factor in women. Rev Cardiovasc Med 2009;10:83-90.
61. United States, Maternal and Child Health Bureau. Women's health USA 2002. Rockville, MD: U.S. Department of Health and Human Services, Health Resources and Services Administration, Maternal and Child Health Bureau, 2002.
62. Davies GA, Herbert WN. Assessment and management of cardiac disease in pregnancy. J Obstet Gynaecol Can 2007;29:331-336.
63. Mottillo S, Filion KB, Genest J, et al. The metabolic syndrome and cardiovascular risk: A systematic review and meta-analysis. J Am Coll Cardiol 2010;56:1113-1132.
64. Zheng ZJ, Croft JB, Giles WH, Mensah GA. Sudden cardiac death in the United States, 1989 to 1998. Circulation 2001;104:2158-2163.
65. Roth A, Elkayam U. Acute myocardial infarction associated with pregnancy. J Am Coll Cardiol 2008;52:171-180. (Pubitemid 351927266)
66. Schutte JM, Steegers EA, Schuitemaker NW, et al. Rise in maternal mortality in the Netherlands. Br J Obstet Gynaecol 2010;117:399-406.
67. Kuklina EV, Callaghan WM. Cardiomyopathy and other myocardial disorders among hospitalizations for pregnancy in the United States: 2004-2006. Obstet Gynecol 2010;115:93-100.
68. Kennedy S, Yudkin P, Greenall M. Cancer in pregnancy. Eur J Surg Oncol 1993;19:405-407. (Pubitemid 23299679)
69. Kaiser HE, Nawab E, Nasir A, Chmielarczyk W, Krenn M. Neoplasms during the progression of pregnancy. In Vivo 2000;14:277-285. (Pubitemid 30189239)
70. Smith LH, Danielsen B, Allen ME, Cress R. Cancer associated with obstetric delivery: Results of linkage with the California Cancer Registry. Am J Obstet Gynecol 2003;189:1128-1135. (Pubitemid 37373909)
71. Andersson TM, Johansson AL, Hsieh CC, Cnattingius S, Lambe M. Increasing incidence of pregnancy-associated breast cancer in Sweden. Obstet Gynecol 2009;114:568-572.
72. Nicklas AH, Baker ME. Imaging strategies in the pregnant cancer patient. Semin Oncol 2000;27:623-632.
73. Marchant DJ. Breast cancer in pregnancy. Clin Obstet Gynecol 1994;37:993-997. (Pubitemid 24354401)
74. Cetin I, Cozzi V, Antonazzo P. Infertility as a cancer risk factor - A review. Placenta 2008;29 (Suppl B):169-177.
75. Brinton L. Long-term effects of ovulation-stimulating drugs on cancer risk. Reprod Biomed Online 2007;15:38-44. (Pubitemid 47162093)
76. Goldberg GL, Runowicz CD. Ovarian carcinoma of low malignant potential, infertility, and induction of ovulation - Is there a link? Am J Obstet Gynecol 1992;166:853-854.
77. Kanakas N, Mantzavinos T. Fertility drugs and gynecologic cancer. Ann NY Acad Sci 2006;1092:265-278. (Pubitemid 47092343)
78. Salhab M, Al SW, Mokbel K. In vitro fertilization and breast cancer risk: A review. Int J Fertil Womens Med 2005;50:259-266.
79. Balady GJ, Chaitman B, Driscoll D, et al. Recommendations for cardiovascular screening, staffing, and emergency policies at health/fitness facilities. Circulation 1998;97:2283-2293. (Pubitemid 28265396)
80. Screening for coronary heart disease: Recommendation statement. Ann Intern Med 2004;140:569-572.
81. Thompson PD, Buchner D, Pina IL, et al. Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: A statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity). Circulation 2003;107:3109-3116. (Pubitemid 36758987)
82. Kaplan EB, Sheiner LB, Boeckmann AJ, et al. The usefulness of preoperative laboratory screening. JAMA 1985;253:3576-3581. (Pubitemid 15057010)
83. Narr BJ, Hansen TR, Warner MA. Preoperative laboratory screening in healthy Mayo patients: Cost-effective elimination of tests and unchanged outcomes. Mayo Clin Proc 1991;66:155-159.
84. Narr BJ, Warner ME, Schroeder DR, Warner MA. Outcomes of patients with no laboratory assessment before anesthesia and a surgical procedure. Mayo Clin Proc 1997;72:505-509. (Pubitemid 27330259)
85. Velanovich V. How much routine preoperative laboratory testing is enough? Am J Med Qual 1993;8:145-151.
86. Practice advisory for preanesthesia evaluation: A report by the American Society of Anesthesiologists Task Force on Preanesthesia Evaluation. Anesthesiology 2002;96:485-496.
87. van Klei WA, Bryson GL, Yang H, Kalkman CJ, Wells GA, Beattie WS. The value of routine preoperative electrocardiography in predicting myocardial infarction after noncardiac surgery. Ann Surg 2007;246:165-170. (Pubitemid 47196510)
88. Screening for obesity in adults: Recommendations and rationale. Ann Intern Med 2003;139:930-932.
89. Dunlop AL, Jack BW, Bottalico JN, et al. The clinical content of preconception care: Women with chronic medical conditions. Am J Obstet Gynecol 2008;199:S310-S327.
90. American College of Obstricians and Gynecologists. Committee opinion No. 452: Primary and preventive care: Periodic assessments. Obstet Gynecol 2009;114:1444-1451.
91. American College of Obstetricians and Gynecologists. committee opinion No. 319, October 2005. The role of obstetrician-gynecologist in the assessment and management of obesity. Obstet Gynecol 2005;106:895-899.
92. Campos-Outcalt D. USPSTF scales back approach to lipid screening for women. J Fam Pract 2008;57:740-742.
93. Standards of medical care in diabetes - 2009. Diabetes Care 2009;32 (Suppl 1):S13-S61.
94. Balen AH, Anderson RA. Impact of obesity on female reproductive health: British Fertility Society, policy and practice guidelines. Hum Fertil (Camb) 2007;10:195-206. (Pubitemid 350215066)
95. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: A systematic review and meta-analysis. JAMA 2004;292:1724-1737. (Pubitemid 39346675)
96. Mechanick JI, Kushner RF, Sugerman HJ, et al. American Association of Clinical Endocrinologists, TheObesity Society, and American Society for Metabolic & Bariatric Surgery medical guidelines for clinical practice for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient. Obesity 2009;17 (Suppl 1):S1-70.
97. Guelinckx I, Devlieger R, Vansant G. Reproductive outcome after bariatric surgery: A critical review. Hum Reprod Update 2009;15:189-201.
98. Abalos E, Duley L, Steyn DW, Henderson-Smart DJ. Anti-hypertensive drug therapy for mild to moderate hypertension during pregnancy. Cochrane Database System Review 2007:CD002252.
99. Weiss AM. Cardiovascular disease in women. Primary Care 2009;36:73-102.
100. Kazmin A, Garcia-Bournissen F, Koren G. Risks of statin use during pregnancy: A systematic review. J Obstet Gynaecol Can 2007;29:906-908.
101. Casey BM, Dashe JS, Wells CE, et al. Subclinical hypothyroidism and pregnancy outcomes. Obstet Gynecol 2005;105:239-245. (Pubitemid 40229436)
102. Haddow JE, Palomaki GE, Allan WC, et al. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child. N Engl J Med 1999;341:549-555. (Pubitemid 29384162)
103. Allan WC, Haddow JE, Palomaki GE, et al. Maternal thyroid deficiency and pregnancy complications: Implications for population screening. J Med Screen 2000;7:127-130.
104. Gharib H, Tuttle RM, Baskin HJ, Fish LH, Singer PA, McDermott MT. Consensus statement 1: Subclinical thyroid dysfunction: A joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and The Endocrine Society. Thyroid 2005;15:24-28. (Pubitemid 40223495)
105. American College of Obstetricians and Gynecologists. committee opinion No. 381: Subclinical hypothyroidism in pregnancy. Obstet Gynecol 2007;110:959-960.
106. Poppe K, Glinoer D, Tournaye H, et al. Thyroid autoimmunity and female infertility. Verh K Acad Geneeskd Belg 2006;68:357-377.
107. Smith RA, Cokkinides V, Brawley OW. Cancer screening in the United States, 2009: A review of current American Cancer Society guidelines and issues in cancer screening. CA Cancer J Clin 2009;59:27-41.
108. U.S. Preventive Services Task Force. Screening for colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2008;149:627-637.
109. Torrens R, Swan BA. Promoting prevention and early recognition of malignant melanoma. Dermatol Nurs 2009;21:115-122.
110. Farr S, Folger SG, Paulen M, et al. U.S. medical eligibility criteria for contraceptive use, 2010: Adapted from the World Health Organization medical eligibility criteria for contraceptive use, 4th ed. MMWR Recomm Rep 2010;59:1-86.